SciencesPlămădeală Johnson Victoria
Main achievement
Consultant in the biostatistical innovations department at the British company GSK
About
Victoria Plămădeală Johnson is a scholar with a significant career in the sciences, particularly in the field of statistics applied to clinical research in oncology. She has an international career in the United States of America, where she has become a respected voice in statistical methodology for clinical trials in the pharmaceutical field. She contributes to the development of innovative statistical models for the design and analysis of clinical trials, facilitating the regulation and efficient implementation of new therapies. Within the pharmaceutical industry, Victoria Plămădeală Johnson holds high-level leadership positions in companies such as GSK and Merck, where she coordinates innovation hubs in statistics and data science, providing methodological support for various stages of drug development. She has been responsible for the design, analysis, and reporting of clinical trials in oncology, including adaptive designs and trial platforms, and has been directly involved in interactions with regulatory authorities. She is also an active member of international networks for leaders and entrepreneurs, where she shares her experience in adopting data and statistics in healthcare decision-making. On a personal level, Victoria Plămădeală Johnson leverages a balance between Romanian tradition and an international career, utilizing her multilingual skills for both professional endeavors and the communication of scientific ideas. Although detailed public information about her family and personal life is limited, her constant involvement in education, research, and professional development indicates a person dedicated not only to research but also to the training of young generations of specialists in statistics and data science. Through her transdisciplinary work, she becomes an example of a woman who propels her cultural and academic background into an international context, contributing significantly to progress in the field of medical sciences and the development of new therapies.
